2.Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proceedings of the National Academy of Sciences. 2009
3.Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling. Proceedings of the National Academy of Sciences. 2014
4.Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer. Breast Cancer Research. 2015
5.A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer. Science Translational Medicine. 2021

• 衛生室|《鄉村醫生診療口袋書(先行本)》面世
• 魯南制藥集團|菏澤醫學?？茖W?！棒斈现扑幃a業學院”揭牌
• 收發|一圖讀懂 | 科學收取快遞 做好健康防護
• 解讀|《浙江省醫院門診管理辦法》政策解讀
• 方面|“四九”第一天，科學養生，健康過冬
• 廉東波|《健談》觀點丨淺表性胃炎三五年復查一次 萎縮性胃炎一年一查
• 家長|杭州《青少年皮膚健康狀況調研》發布，近半青少年受皮膚疾病困擾
• 李大可|八成女性都有可能感染HPV！科學預防很關鍵
• 疫苗|戴口罩真的很重要！流調人員：佩戴口罩不科學，風險等級則從嚴判斷
• 公報,監測,國民,體質|一圖讀懂《第五次國民體質監測公報》